Innohep

DRUG3 trials

Sponsors

Rigshospitalet, Duke University, Michalis Karamouzis

Conditions

Acute critical illness requiring intensive care unit admission.Pancreatic CancerPrimary Brain TumorThromboembolism

Phase 3

The Impact of Thromboprophylaxis on Progression Free Survival of Patients With Advanced Pancreatic Cancer

Michalis KaramouzisPancreatic Cancer, Thromboembolism

Start: 2022-02-10End: 2024-12-31Target: 450Updated: 2022-03-29

Phase 4

The Intensive Care Platform Trial (INCEPT)

RecruitingCTIS2024-516208-41-00

RigshospitaletAcute critical illness requiring intensive care unit admission.

Start: 2025-06-26Target: 20000Updated: 2025-12-22

Unknown Phase

Innohep for Prophylaxis of Venous Thromboembolism in Brain Tumor Patients

CompletedNCT00629447

Duke UniversityPrimary Brain Tumor

Start: 2004-02-29End: 2009-10-31Updated: 2013-01-07